Immunoscintigraphic evaluation of lymph node involvement in prostatic carcinoma

Area of Science:

• Oncology
• Nuclear Medicine
• Immunology

Background:

• Accurate preoperative staging is crucial for effective prostate cancer treatment planning.
• Identifying lymph node involvement impacts therapeutic strategies and patient prognosis.
• Current staging methods may have limitations in detecting small or distant metastases.

Purpose of the Study:

• To evaluate the feasibility of using radiolabeled monoclonal antibodies for preoperative staging of prostate cancer.
• To assess the ability of this technique to detect lymph node metastases.
• To determine if antibody uptake in cancer cells correlates with disease presence.

Main Methods:

• Five patients undergoing radical prostatectomy were injected with 99mTc-labeled F(ab')2 fragments of monoclonal antibodies against prostatic acid phosphatase into the periprostatic space.
• Dynamic imaging was performed at 1, 6, and 24 hours post-injection.
• Positive findings were confirmed with staging pelvic lymphadenectomy and immunolabeling electron microscopy.

Main Results:

• Lymph node metastases were detected in one patient in the left paraaortic, iliac, and obturator nodes.
• These metastatic lesions were confirmed by lymphadenectomy and electron microscopy.
• No metastases were detected in the other four patients, with negative surgical confirmation.

Conclusions:

• Radiolabeled monoclonal antibody injection into the periprostatic space shows promise for preoperative staging of prostate cancer.
• The technique may aid in identifying lymph node involvement, influencing surgical and treatment decisions.
• Further studies are warranted to validate these early findings in a larger cohort.